Low-dose buprenorphine given after a single treatment of ketamine reduced suicidal ideation by 76% in adults with major depressive disorder, findings show.The encouraging data come during a severe mental health crisis in the U.S., as “about 13 million people seriously consider suicide annually,” study co-author Alan F. Schatzberg, MD, the Kenneth T. Norris Jr. Professor in Psychiatry